PubMed · 2127105
Engineering a novel beta-lactamase by a single point mutation.
Abstract
beta-Lactamases are widespread and efficient bacterial enzymes which play a major role in bacterial resistance to penicillins and cephalosporins. In order to elucidate the role of the residues lying in a conserved loop of the enzymatic cavity of the active-site serine Streptomyces albus G beta-lactamase, modified proteins were produced by oligo-directed mutagenesis. Mutation of Asn116, which lies on one side of the active site cavity pointing to the substrate-binding site, into a serine residue resulted in spectacular modifications of the specificity profile of the enzyme. That replacement yielded an enzyme with a nearly unchanged activity towards good penicillin substrates. In sharp contrast its efficiency in hydrolysing cephalosporins was drastically reduced, the best substrates suffering the largest decrease in the second-order rate constant for serine acylation. In fact that single mutation generated a truly new enzyme behaving exclusively as a penicillinase, a situation which is never encountered to the same degree in any of the numerous naturally occurring variants of class A beta-lactamases.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
F Jacob, B Joris, O Dideberg, J Dusart, J M Ghuysen, J M Frère. 1990. Engineering a novel beta-lactamase by a single point mutation.. https://doi.org/10.1093/protein%2F4.1.79
Cite the original work for its findings. Save a collection to share your selection of sources.